Your browser doesn't support javascript.
loading
Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation.
Sainski, Amy M; Dai, Haiming; Natesampillai, Sekar; Pang, Yuan-Ping; Bren, Gary D; Cummins, Nathan W; Correia, Cristina; Meng, X Wei; Tarara, James E; Ramirez-Alvarado, Marina; Katzmann, David J; Ochsenbauer, Christina; Kappes, John C; Kaufmann, Scott H; Badley, Andrew D.
Afiliação
  • Sainski AM; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294 Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, D
  • Dai H; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294.
  • Natesampillai S; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294.
  • Pang YP; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294.
  • Bren GD; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294.
  • Cummins NW; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294.
  • Correia C; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294.
  • Meng XW; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294 Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, D
  • Tarara JE; Department of Biochemistry and Molecular Biology and Department of Molecular Medicine, Mayo Clinic, Rochester MN 55905.
  • Ramirez-Alvarado M; Department of Biochemistry and Molecular Biology and Department of Molecular Medicine, Mayo Clinic, Rochester MN 55905.
  • Katzmann DJ; Department of Biochemistry and Molecular Biology and Department of Molecular Medicine, Mayo Clinic, Rochester MN 55905.
  • Ochsenbauer C; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294.
  • Kappes JC; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294.
  • Kaufmann SH; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294 Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, D
  • Badley AD; Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294 Department of Biochemistry and Molecular Biology and Department of Molecular Medicine, Mayo Clinic
J Cell Biol ; 206(7): 867-76, 2014 Sep 29.
Article em En | MEDLINE | ID: mdl-25246614
ABSTRACT
Previous studies have shown that human immunodeficiency virus (HIV) protease cleaves procaspase 8 to a fragment, termed Casp8p41, that lacks caspase activity but nonetheless contributes to T cell apoptosis. Herein, we show that Casp8p41 contains a domain that interacts with the BH3-binding groove of pro-apoptotic Bak to cause Bak oligomerization, Bak-mediated membrane permeabilization, and cell death. Levels of active Bak are higher in HIV-infected T cells that express Casp8p41. Conversely, targeted mutations in the Bak-interacting domain diminish Bak binding and Casp8p41-mediated cell death. Similar mutations in procaspase 8 impair the ability of HIV to kill infected T cells. These observations support a novel paradigm in which HIV converts a normal cellular constituent into a direct activator that functions like a BH3-only protein.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Protease de HIV / HIV-1 / Apoptose / Proteína Killer-Antagonista Homóloga a bcl-2 / Caspase 8 Limite: Humans Idioma: En Revista: J Cell Biol Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Protease de HIV / HIV-1 / Apoptose / Proteína Killer-Antagonista Homóloga a bcl-2 / Caspase 8 Limite: Humans Idioma: En Revista: J Cell Biol Ano de publicação: 2014 Tipo de documento: Article